Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jun 03, 2024

BUY
$54.2 - $71.67 $1.35 Million - $1.78 Million
24,900 New
24,900 $1.63 Million
Q2 2023

Jun 03, 2024

BUY
$56.23 - $71.17 $1.4 Million - $1.77 Million
24,900 New
24,900 $1.45 Million
Q1 2023

May 28, 2024

BUY
$53.43 - $68.12 $1.33 Million - $1.7 Million
24,900 New
24,900 $1.54 Million
Q3 2021

Oct 14, 2021

SELL
$71.29 - $95.99 $107,148 - $144,272
-1,503 Reduced 5.69%
24,900 $2.02 Million
Q2 2021

Jul 20, 2021

SELL
$79.62 - $114.85 $293,797 - $423,796
-3,690 Reduced 12.26%
26,403 $2.46 Million
Q1 2021

May 05, 2021

BUY
$77.91 - $125.92 $1.51 Million - $2.45 Million
19,422 Added 182.01%
30,093 $3.22 Million
Q4 2020

Jan 13, 2021

BUY
$60.0 - $87.29 $640,260 - $931,471
10,671 New
10,671 $931,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.24B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.